"We Can Do It All" Is a Red Flag: What 8 Years of Chemical Procurement Taught Me

There's one sentence that makes me mentally check out of a sales call: "We can handle everything you need."

I've managed procurement for a mid-sized chemical buying operation for eight years. We spend roughly $400,000 annually across APIs, cell culture media, reagents, and specialty materials. Maybe $450,000—I'd have to check the Q4 close, but the ballpark is right. And the thing I've learned from tracking every purchase order, every invoice, and every vendor relationship in that time is straightforward: a supplier who tells you what they're not good at is worth ten who claim to be good at everything.

That sounds counterintuitive. I know. But in the chemical supply world, "yes we can" from the wrong person doesn't just waste your budget—it creates compliance gaps, audit findings, and batches that quietly fail. That isn't a risk worth taking to save 5% on a unit price.

The Illusion of the One-Stop Shop

People think a bigger supplier catalog means lower total cost. One vendor, one contract, one invoice—the assumption is that consolidating your spend gives you more leverage and less paperwork.

The reality is that the causation runs the other way. Suppliers who consistently deliver quality on a narrow set of products can charge more because their expertise is worth it. Suppliers who claim they can "do it all" usually deliver mediocrity across the board—and you find that out after the batch fails and the QC documentation comes back incomplete.

I've seen this pattern many times. But when I say "many," I'm not talking about a handful of cases. I mean consistently, across 200+ purchase orders logged in our procurement system. It doesn't matter if it's a simple reagent order or a custom synthesis project—the pattern repeats.

The GMP API Lesson: Specialist or Nothing

Take the time we needed a GMP-certified API manufacturer for a clinical-stage project. The shortlist split into two camps. The first was large chemical distributors who assured us they could source and manufacture "anything, including APIs." The second was dedicated CDMOs like Lonza, whose entire business model is pharmaceutical manufacturing under GMP compliance.

I had two weeks to make the call before the project timeline fell apart. Normally I'd run a full RFQ process and build a TCO spreadsheet—I created one after getting burned on hidden fees twice—but there was no time. So I leaned on the only thing that matters when you can't verify everything fast enough: how easily can you check their claims?

Lonza's GMP credentials were easy to verify. Their API manufacturing capabilities are documented down to the equipment level. In the pharma world, the API Lonza supplies to customers has to pass the same scrutiny from auditors that our own quality team would apply. Their cell culture media products—RPMI-1640, DMEM—have been industry standards for decades. When a supplier's entire business depends on passing regulatory scrutiny, they tend to be careful about what they claim.

The "we can do APIs too" distributors, by contrast, couldn't produce a single batch record that satisfied our QA team. Their sales reps kept pointing to catalog size. That's when I realized: catalog size and manufacturing competence are two unrelated metrics.

The most frustrating part of that experience is what happens downstream when a supplier overpromises. You'd think written specifications would prevent misunderstandings, but interpretation varies wildly. We once spent four months qualifying a different supplier, then watched the trial batch fail because they hadn't run that specific reaction at scale. The redo cost us $1,200 and a weekend of my life. What finally helped was a new policy: no documentary evidence of experience with the exact process, no shortlist.

Commodity Chemicals Still Need Specialists

Here's where people push back: "Fine for complex APIs. But commodity chemicals? Anyone can supply those."

I get why people think that. Budgets are real, and I've made purchases based on price alone when the materials were truly commoditized. But even "simple" chemicals hide complexity in the spec sheets.

Take sulfuric acid. The chemical symbol for sulfuric acid is H₂SO₄—that's basic chemistry. But the procurement specs go far beyond the formula:

• Concentration: a 0.5N solution and concentrated acid aren't interchangeable
• Grade: reagent, GMP, analytical—three different products with three different documentation requirements
• Traceability: where the raw materials originate, what regulatory restrictions apply to the supply chain
• Stability data: how the product holds up in transport and storage

I once reviewed a quote for sodium hydroxide solution 0.5N where the new vendor's price came in 30% below our incumbent. I almost went with them until I checked the spec sheet: no GMP compliance documentation. The "cheap" option would have meant a $1,200 redo when our QA flagged it during the audit. I still remember that number because it was completely avoidable.

So when I hear "it's just a commodity chemical," I translate that to: someone with deep expertise keeps this boring, but an amateur turns it into an incident. The specialist's value isn't just making the chemical—it's the regulatory completeness in the documentation that makes the purchase actually usable.

What Products Have Titanium Dioxide? More Than You'd Think

Another example that surprises people: titanium dioxide, or TiO₂. It looks like the simplest possible purchase—a white powder that goes into everything. Then you try to source it across multiple applications and the picture changes.

So, what products have titanium dioxide? A quick rundown:

• Paints and coatings—the largest use by volume. A paint shop needs pigment-grade TiO₂ for opacity and brightness
• Plastics—as a whitener and UV stabilizer
• Sunscreen—but only the non-nano UV-filter grade, which is a completely different specification
• Food products—as a whitening agent, though this use is under regulatory pressure in the EU
• Cosmetics—with its own purity and safety documentation requirements

Each application demands a different particle size, surface treatment, purity level, and regulatory file. The TiO₂ grade a paint shop uses doesn't satisfy pharmaceutical specifications, and the pharma grade is roughly four times the price.

So when a supplier whose primary customers are paint shops claims equal expertise in cosmetic-grade TiO₂, alarm bells go off. I've watched a vendor pitch a "universal" TiO₂ that passed only one of the four application-specific certifications we required. Their marketing said one thing; the lab results said another.

Per FTC guidelines (ftc.gov), advertising claims need to be truthful and substantiated. But in B2B procurement, the customer enforces that rule faster than any regulator. Overclaim once, and you don't just lose one order—you lose the whole account.

That's why I've learned to value the sales rep who says, "This isn't our strength—here's who does it better." That sentence has earned more of my business than any catalog page. I've heard it exactly twice in eight years. Both of those suppliers got every piece of business I could route their way.

To Be Fair, Breadth Has Its Place

I have mixed feelings about large distributors, and I'll be the first to admit they're the right choice in some situations. On one hand, consolidating routine lab consumables with one supplier is efficient. Volume gives you negotiation leverage, and the convenience of a single invoice and a tested ordering portal is real.

On the other hand, convenience becomes a single point of failure when your actual need falls outside the distributor's depth. "We carry 50,000 products" doesn't mean they understand the regulatory requirements of the one product you absolutely have to get right.

Granted, working with specialists means more vendor contracts, more compliance reviews, more invoice streams. It's an administrative burden, and I won't pretend otherwise. But in my experience, that overhead is small compared to the cost of a failed batch, an audit finding, or a supply interruption caused by a supplier who promised more than they could deliver.

We tested this assumption in 2024 when we overhauled our procurement policy. After tracking 47 orders over 12 months, we found that roughly 18% of our budget overruns came from suppliers who underestimated compliance work during the quoting phase. We implemented a pre-qualification rule requiring documented evidence of relevant experience before a supplier could bid. Overruns dropped to about 9% in the following two quarters.

The Bottom Line

The way I see it, the "one-stop-shop" promise is one of the most dangerous phrases in procurement. A vendor who says "we can do all of that" is either lying about their capabilities or comfortable with ambiguity. Neither is a quality I want in a supplier.

I'll take a specialist who points me elsewhere over a generalist who says yes to everything. It's more paperwork. It's more vendors to manage. But it's also how you get batches that pass inspection, documentation that survives an audit, and invoices that don't contain surprises.

A supplier once told me, "This isn't our strength." They didn't lose my business—they earned the rest of it. That's not a contradiction. It's professional competence. And in my experience, competence is the scarcest material in the entire supply chain.